Estimating the infectivity of HIV from partner studies [published erratum appears in Ann Epidemiol 1992 May;2(3):344-5] NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Estimating the infectivity of HIV from partner studies [published erratum appears in Ann Epidemiol 1992 May;2(3):344-5]

Ann Epidemiol. 1990 Dec;1(2):117-28. Unique Identifier : AIDSLINE MED/94093738
Kim MY; Lagakos SW; Department of Biostatistics, Harvard School of Public Health; Boston, MA.

Abstract: The main sources of data for estimating infectivity of the human immunodeficiency virus (HIV) come from studies of the susceptible partners of individuals known to be infected with HIV. Estimation of infectivity from these studies is complicated by limitations imposed by the sampling designs. This paper reviews three sampling schemes that have been used in partner studies and, for each, proposes methods for estimating various theoretic models for infectivity. The methods, as well as procedures for checking goodness-of-fit, are illustrated using data from a study by Peterman and colleagues.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/*TRANSMISSION Comparative Study Cross-Sectional Studies Female Human Male Models, Statistical Prospective Studies Retrospective Studies Sampling Studies Sex Behavior Support, U.S. Gov't, P.H.S. United States JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDepidemiology/KWDtransmissioncomparativestudycross-sectionalstudiesfemalehumanmalemodels,statisticalprospectivestudiesretrospectivestudiessamplingstudiessexbehaviorsupport,uKWDsKWDgov't,pKWDhKWDsKWDunitedstatesjournalarticle
940430
M9440901

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .